TCT: Bivalirudin Cuts Bleeding in PCI
WASHINGTON (MedPage Today) -- A prolonged infusion of bivalirudin (AngioMax) around percutaneous coronary intervention reduced bleeding compared with heparin, with or without glycoprotein IIb/IIIa inhibition, a Chinese trial showed.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Angiomax | Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention